Wright Medical Group N.V. (WMGI) Given Average Recommendation of “Buy” by Analysts

Wright Medical Group N.V. (NASDAQ:WMGI) has received an average recommendation of “Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $32.13.

Several research firms recently issued reports on WMGI. Needham & Company LLC reaffirmed a “hold” rating on shares of Wright Medical Group N.V. in a research report on Friday, September 1st. BidaskClub raised Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Wright Medical Group N.V. in a research report on Thursday, August 3rd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $33.00 price objective on shares of Wright Medical Group N.V. in a research report on Friday, August 4th. Finally, Robert W. Baird reaffirmed a “buy” rating and issued a $33.00 price objective on shares of Wright Medical Group N.V. in a research report on Friday, October 6th.

WARNING: “Wright Medical Group N.V. (WMGI) Given Average Recommendation of “Buy” by Analysts” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2017/12/05/wright-medical-group-n-v-wmgi-given-average-recommendation-of-buy-by-analysts.html.

In related news, Director Richard F. Wallman acquired 4,000 shares of Wright Medical Group N.V. stock in a transaction dated Friday, November 10th. The stock was purchased at an average cost of $24.00 per share, for a total transaction of $96,000.00. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, SVP Gregory Morrison sold 92,140 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $23.70, for a total value of $2,183,718.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 92,340 shares of company stock valued at $2,189,064. Company insiders own 9.30% of the company’s stock.

Large investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Wright Medical Group N.V. by 11.6% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,797 shares of the medical device company’s stock worth $104,000 after purchasing an additional 396 shares in the last quarter. First Mercantile Trust Co. increased its stake in shares of Wright Medical Group N.V. by 21.7% in the 2nd quarter. First Mercantile Trust Co. now owns 4,380 shares of the medical device company’s stock worth $120,000 after purchasing an additional 780 shares in the last quarter. Fortaleza Asset Management Inc. purchased a new stake in shares of Wright Medical Group N.V. in the 2nd quarter worth $148,000. US Bancorp DE increased its stake in shares of Wright Medical Group N.V. by 41.3% in the 2nd quarter. US Bancorp DE now owns 5,624 shares of the medical device company’s stock worth $155,000 after purchasing an additional 1,644 shares in the last quarter. Finally, Prudential Financial Inc. purchased a new stake in shares of Wright Medical Group N.V. in the 1st quarter worth $219,000.

Wright Medical Group N.V. (WMGI) traded up $0.35 during mid-day trading on Friday, reaching $24.80. The company had a trading volume of 603,702 shares, compared to its average volume of 1,081,441. Wright Medical Group N.V. has a fifty-two week low of $22.14 and a fifty-two week high of $31.53. The company has a current ratio of 1.31, a quick ratio of 0.96 and a debt-to-equity ratio of 1.52.

Wright Medical Group N.V. (NASDAQ:WMGI) last released its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.16) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.16). The business had revenue of $170.50 million for the quarter, compared to analysts’ expectations of $173.50 million. Wright Medical Group N.V. had a negative return on equity of 6.27% and a negative net margin of 38.40%. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.19) EPS. analysts forecast that Wright Medical Group N.V. will post -0.27 EPS for the current year.

Wright Medical Group N.V. Company Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply